Dopamine D1 and corticotrophin‐releasing hormone type‐2α receptors assemble into functionally interacting complexes in living cells
- 1 December 2014
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (24) , 5650-5664
Abstract
Background and Purpose: Dopamine and corticotrophin‐releasing hormone (CRH; also known as corticotrophin‐releasing factor) are key neurotransmitters in the interaction between stress and addiction. Repeated treatment with cocaine potentiates glutamatergic transmission in the rat basolateral amygdala/cortex pathway through a synergistic action of D1‐like dopamine receptors and CRH type‐2α receptors (CRF2α receptors). We hypothesized that this observed synergism could be instrumented by heteromers containing the dopamine D1 receptor and CRF2α receptor.Experimental Approach: D1/CRF2α receptor heteromerization was demonstrated in HEK293T cells using co‐immunoprecipitation, BRET and FRET assays, and by using the heteromer mobilization strategy. The ability of D1 receptors to signal through calcium, when singly expressed or co‐expressed with CRF2α receptors, was evaluated by the calcium mobilization assay.Key Results: D1/CRF2α receptor heteromers were observed in HEK293T cells. When singly expressed, D1 receptors were mostly located at the cell surface whereas CRF2α receptors accumulated intracellularly. Interestingly, co‐expression of both receptors promoted D1 receptor intracellular and CRF2α receptor cell surface targeting. The heteromerization of D1/CRF2α receptors maintained the signalling through cAMP of both receptors but switched D1 receptor signalling properties, as the heteromeric D1 receptor was able to mobilize intracellular calcium upon stimulation with a D1 receptor agonist.Conclusions and Implications: D1 and CRF2α receptors are capable of heterodimerization in living cells. D1/CRF2α receptor heteromerization might account, at least in part, for the complex physiological interactions established between dopamine and CRH in normal and pathological conditions such as addiction, representing a new potential pharmacological target.Keywords
Funding Information
- FONDECYT (1070340, 1110392, 7070246, 7080124 anf 1130079)
- Millenium Science Initiative (MSI) (P06/008-F and P10/063-F)
- MINECO and ICREA Academia-2010 from Catalan Institution for Research and Advanced Studies (ICREA) (SAF2011-24779 and CSD2008-00005)
This publication has 61 references indexed in Scilit:
- Enhanced Upregulation of CRH mRNA Expression in the Nucleus Accumbens of Male Rats after a Second Injection of Methamphetamine Given Thirty Days LaterPLOS ONE, 2014
- Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease RelevanceNeuropsychopharmacology, 2013
- Role of CRF and other neuropeptides in stress-induced reinstatement of drug seekingBrain Research, 2010
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006
- Chronic Cocaine Administration Switches Corticotropin-Releasing Factor2Receptor-Mediated Depression to Facilitation of Glutamatergic Transmission in the Lateral SeptumJournal of Neuroscience, 2005
- Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium SignalJournal of Biological Chemistry, 2004
- Adenosine A2A-Dopamine D2 Receptor-Receptor HeteromerizationJournal of Biological Chemistry, 2003
- Coexpression of δ-Opioid Receptors with μ Receptors in GH3 Cells Changes the Functional Response to μ Agonists from Inhibitory to ExcitatoryMolecular Pharmacology, 2003
- Distinct Dynamin-dependent and -independent Mechanisms Target Structurally Homologous Dopamine Receptors to Different Endocytic MembranesJournal of Cell Biology, 1999